Paul Hastings has advised CDH Genetech Limited (“CDH”), part of the CDH Investments group, on its agreement (together with Hong Kong-listed China Grand Pharmaceutical and Healthcare…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
